UNIGE document Scientific Article
previous document  unige:32434  next document
add to browser collection

In vivo study of HCV in mice with chimeric human livers

Kneteman, Norman M
Published in Methods in Molecular Biology. 2009, vol. 510, p. 383-99
Abstract Estimates of hepatitis C virus infection include 170 million people worldwide, who face increased risk of development of cirrhosis, liver failure, and hepatocellular carcinoma. Standard of care therapy with pegylated interferon and ribavirin is effective in just half of patients, is challenged by substantial treatment-related morbidity, and is prohibitively expensive in most parts of the world. New therapeutics for treatment and prevention are clearly needed. Development of effective therapies has been significantly hampered by difficulties in establishing in vitro and in vivo models of viral replication. This chapter reviews development, validation, and early application of a mouse model with a chimeric human liver.
Keywords AnimalsChimera/virologyDisease Models, AnimalHepacivirus/physiologyHepatitis C/pathology/virologyHumansLiver/cytology/pathology/virologyMiceReproducibility of ResultsVirus Cultivation/methodsVirus Replication/physiology
PMID: 19009277
Full text
Article (Published version) (671 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Transplantation et hépatologie (905)
(ISO format)
KNETEMAN, Norman M, TOSO, Christian. In vivo study of HCV in mice with chimeric human livers. In: Methods in Molecular Biology, 2009, vol. 510, p. 383-99. doi: 10.1007/978-1-59745-394-3_29 https://archive-ouverte.unige.ch/unige:32434

320 hits

0 download


Deposited on : 2013-12-18

Export document
Format :
Citation style :